SMASH, NCT03049267: Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative Hidradenitis |
|
|
| Completed | 2 | 20 | Europe | Apremilast, Otezla, CC-10004, Placebo Oral Tablet, Placebo comparator | M.B.A. van Doorn, Celgene | Hidradenitis Suppurativa | 12/17 | 06/18 | | |
